Heparin-based, injectable microcarriers for controlled delivery of interleukin-13 to the brain

Biomater Sci. 2020 Sep 15;8(18):4997-5004. doi: 10.1039/d0bm01249a.

Abstract

Interleukin-13 (IL-13) drives cells of myeloid origin towards a more anti-inflammatory phenotype, but delivery to the brain remains problematic. Herein, we show that heparin-based cryogel microcarriers load high amounts of IL-13, releasing it slowly. Intra-striatal injection of loaded microcarriers caused local up-regulation of ARG1 in myeloid cells for pro-regenerative immunomodulation in the brain.

MeSH terms

  • Brain
  • Cryogels
  • Heparin*
  • Interleukin-13*

Substances

  • Cryogels
  • Interleukin-13
  • Heparin